These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 32063104

  • 1. Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.
    Solana-Altabella A, Valero S, Balaguer J, Escobar-Cava P, Barranco H, López E, Ribes-Artero H, Poveda JL.
    J Oncol Pharm Pract; 2020 Dec; 26(8):1829-1835. PubMed ID: 32063104
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients.
    Bogan CM, Pierce JM, Doss SD, Tao YK, Chen SC, Boyd KL, Liao A, Hsieh T, Abramson DH, Francis JH, Friedman DL, Richmond A, Daniels AB.
    Exp Eye Res; 2021 Mar; 204():108439. PubMed ID: 33444583
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications.
    Munier FL, Gaillard MC, Balmer A, Soliman S, Podilsky G, Moulin AP, Beck-Popovic M.
    Br J Ophthalmol; 2012 Aug; 96(8):1078-83. PubMed ID: 22694968
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pathological findings in enucleated eyes after intravitreal melphalan injection.
    Ghassemi F, Amoli FA.
    Int Ophthalmol; 2014 Jun; 34(3):533-40. PubMed ID: 24043335
    [Abstract] [Full Text] [Related]

  • 11. The classification of vitreous seeds in retinoblastoma and response to intravitreal melphalan.
    Francis JH, Abramson DH, Gaillard MC, Marr BP, Beck-Popovic M, Munier FL.
    Ophthalmology; 2015 Jun; 122(6):1173-9. PubMed ID: 25795478
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
    Shields CL, Douglass AM, Beggache M, Say EA, Shields JA.
    Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
    [Abstract] [Full Text] [Related]

  • 14. Intravitreal injection of melphalan in the treatment of retinoblastoma with vitreous cavity seeding.
    Sun YB, Hui P, Punyara K, Bi MC, Li SH, Teng SY, Song E.
    Chin Med J (Engl); 2013 Jun; 126(8):1587. PubMed ID: 23595400
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intravitreal Lower-Dose (20 µg) Melphalan for Persistent or Recurrent Retinoblastoma Vitreous Seeds.
    Tuncer S, Balcı Ö, Tanyıldız B, Kebudi R, Shields CL.
    Ophthalmic Surg Lasers Imaging Retina; 2015 Oct; 46(9):942-8. PubMed ID: 26469234
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.